Get the Stockscreener App
4.52
0.44%
0.02
After Hours:
4.58
0.06
+1.33%
Champions Oncology Inc stock is traded at $4.52, with a volume of 3,758.
It is up +0.44% in the last 24 hours and up +2.26% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$4.50
Open:
$4.38
24h Volume:
3,758
Relative Volume:
0.07
Market Cap:
$62.12M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-8.0542
EPS:
-0.5612
Net Cash Flow:
$-4.86M
1W Performance:
+0.22%
1M Performance:
+2.26%
6M Performance:
-3.83%
1Y Performance:
-17.37%
1-Day Range:
$4.34
$4.58
1-Week Range:
$4.34
$4.70
52-Week Range:
$3.6001
$7.1303
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| CSBR | 4.52 | 62.12M | 49.98M | -9.64M | -4.86M | -0.5612 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago - Yahoo Finance
Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth - Simply Wall St
Shangri-La Mactan champions Breast Cancer Awareness with 'Pink Path to Hope' Fun Run and Wellness Forum - SunStar Philippines
CancerX Launches Expanded Accelerator Program for 2025, Partnering With KidsX to Transform Cancer Care Innovation - 01Net
Custom Assay Development Service Market Size, Share, Growth Forecast and Trends Analysis (2024-2032) - Economica
Patient Derived Xenograft Model Market Set for Explosive Growth - openPR
Champions Oncology announces stockholder meeting results - Investing.com India
Champions Oncology secures Weill Cornell PDX models license - Investing.com
Champions Oncology secures Weill Cornell PDX models license By Investing.com - Investing.com UK
Champions Oncology Announces Agreement with Weill Cornell Medicine - AccessWire
Champions Oncology announces stockholder meeting results By Investing.com - Investing.com UK
Florida Today EventsPremier Boxing ChampionsTszyu v Murtazaliev - Florida Today
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Champions Oncology Announces Sudden Loss of President - TipRanks
Champions Oncology President Brady Davis Dies >CSBR - MarketWatch
Champions Oncology, Inc. Announces Demise of Brady Davis as President - Marketscreener.com
CN Energy Group (NASDAQ:CNEY) Stock Quotes, Forecast and News Summary - Benzinga
Patient Derived Xenograft or PDX Models Market Growth Factors & Key Statistics - Economica
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business - Yahoo Finance
Magnetar Financial LLC Buys Shares of 2,193,929 ChampionX Co. (NASDAQ:CHX) - Defense World
Its Stock Has Paid Off Big Time For Champion Homes Inc. - SETE News
P Schoenfeld Asset Management LP Makes New $5.45 Million Investment in ChampionX Co. (NASDAQ:CHX) - Defense World
Potential Price Increase for Champion Homes Inc. (SKY) After Recent Insider Activity - Knox Daily
Ameritas Investment Partners Inc. Has $1.97 Million Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World
DekaBank Deutsche Girozentrale Makes New Investment in ChampionX Co. (NASDAQ:CHX) - Defense World
Renaissance Technologies LLC Takes Position in ChampionX Co. (NASDAQ:CHX) - MarketBeat
Benjamin Edwards Inc. Increases Stake in ChampionX Co. (NASDAQ:CHX) - Defense World
622,616 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Renaissance Technologies LLC - Defense World
CHX Shares Experience Surge in Value - Knox Daily
6,878 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Choreo LLC - Defense World
ChampionX Co. (NASDAQ:CHX) Shares Sold by Oppenheimer Asset Management Inc. - Defense World
Seven Eight Capital LP Acquires Shares of 56,674 ChampionX Co. (NASDAQ:CHX) - Defense World
Mutual of America Capital Management LLC Sells 237,847 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World
Victory Capital Management Inc. Sells 56,930 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World
State of New Jersey Common Pension Fund D Trims Stake in ChampionX Co. (NASDAQ:CHX) - Defense World
Cybersecurity Awareness Month Champion Organizations - National Cyber Security Alliance
Meeder Advisory Services Inc. Has $217,000 Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World
Tumor Mice Model Market Detailed Summary, Industry Size and Future Growth Prospects To 2024-2032 - Cauverynews
Local official champions Blood Cancer Awareness Month to boost education - WTOV Steubenville
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - MSN
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday - MSN
Champions Oncology First Quarter 2025 Earnings: EPS: US$0.097 (vs US$0.19 loss in 1Q 2024) - Simply Wall St
Champions Oncology upgraded to buy by Craig-Hallum - MSN
What is CSBR’s price-to-sales ratio telling us about the company’s value? - US Post News
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 By Investing.com - Investing.com Australia
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 - Investing.com India
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2024 - Marketscreener.com
Stocks to Watch: Oxford Industries, Mobile Infrastructure, Champions Oncology - MarketWatch
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):